Summary: Breast cancer can quickly disturb the brain’s regulation of day-night stress hormones, even before tumors are detectable. In mice, the disease flattens normal corticosterone cycles by altering the activity of hypothalamic neurons. Those changes can worsen symptoms commonly reported by cancer patients—insomnia, anxiety, and fatigue—and may contribute to poorer outcomes.
Remarkably, restoring the brain’s natural timing reinstated healthy stress-hormone rhythms and increased anti-tumor immune activity, producing measurable tumor shrinkage. These results suggest that stabilizing circadian and hormonal rhythms, in addition to targeting tumor cells directly, could improve treatment effectiveness and patient well-being.
Key Facts:
- Rapid hormone rhythm disruption: In mice, breast cancer reduces normal day-night corticosterone rhythms by about 40–50% within three days of tumor induction.
- Identified neural mechanism: Paraventricular hypothalamic neurons (PVNCRH) become abnormally active but produce low effective output due to disinhibition from upstream GABAergic neurons, flattening glucocorticoid cycles.
- Restoring rhythms improves immunity: Timed stimulation of hypothalamic neurons re-established glucocorticoid rhythms, increased CD8+ T cell infiltration into tumors, and slowed tumor progression.
Source: CSHL
“The brain is an exquisite sensor of what’s going on in your body,” says Cold Spring Harbor Laboratory Assistant Professor Jeremy Borniger.
“But it needs balance. Neurons must be active at the right times and quiet at others. Even small disruptions in that timing can change how circuits operate and alter whole-body physiology.”
In this study, the Borniger lab tracked how breast tumors affect diurnal rhythms of corticosterone, the main stress hormone in rodents (analogous to cortisol in humans). Under normal conditions, corticosterone levels rise and fall predictably across the day and night. In tumor-bearing mice, that rhythm became markedly flattened, a change associated with reduced quality of life and increased mortality in clinical observations.
Disrupted diurnal rhythms are linked to sleep disturbances, anxiety, and impaired stress responses—symptoms frequently experienced by people with cancer. These rhythms are coordinated by the hypothalamic-pituitary-adrenal (HPA) axis, a feedback loop between the hypothalamus, pituitary gland, and adrenal glands that maintains appropriate glucocorticoid timing.
Surprisingly, the team observed that rhythm disruption occurred very early: “Even before tumors were palpable, we saw roughly a 40 to 50% blunting of the corticosterone rhythm,” Borniger reports. “This change appeared within three days of inducing the cancer.”
Examining the hypothalamus revealed that PVN neurons expressing corticotropin-releasing hormone (PVNCRH) were stuck in a hyperactive but functionally low-output state. That dysfunctional pattern appeared to stem from loss of inhibitory input from upstream GABAergic neurons. Using chemogenetics to stimulate PVNCRH neurons at specific times, the researchers were able to mimic the natural day-night activity pattern and restore normal hormone cycles.
When the researchers re-established that timing—stimulation delivered just before the light-to-dark transition—corticosterone rhythms returned, anti-tumor CD8+ T cells increased inside the tumors, and tumor growth slowed. Importantly, the beneficial effect depended on precise timing: the same stimulation at the wrong time of day did not produce these immune or anti-tumor effects.
“Enforcing a correct daily rhythm boosted the immune system’s ability to fight the cancer,” Borniger says. “We still need to understand the exact mechanisms, but the timing clearly matters.”
The research team is now investigating how signals from tumors reach and disrupt the hypothalamus, and whether similar mechanisms operate in humans. Borniger emphasizes that these interventions did not involve chemotherapy or other anti-cancer drugs: instead, restoring physiological balance alone produced measurable anti-tumor benefits in mice.
“Our focus was on making the patient’s physiology as healthy as possible,” he explains. “Improving circadian and hormonal regulation may enhance existing therapies, increase their effectiveness, and potentially reduce treatment-related toxicity.”
Key Questions Answered:
A: Tumors disrupt hypothalamic neuron activity, particularly PVNCRH circuits, which flattens normal day-night glucocorticoid rhythms well before tumors are physically detectable.
A: Altered rhythms can worsen sleep and mood, impair stress responses, and weaken immune function, all of which are linked to lower quality of life and poorer clinical outcomes.
A: In this mouse model, yes—restoring correct brain timing revived glucocorticoid rhythms, increased tumor infiltration by effector T cells, and reduced tumor progression.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The full journal paper was reviewed.
- Additional context was provided by editorial staff.
About this cancer and neuroscience research news
Author: Samuel Diamond
Source: CSHL
Contact: Samuel Diamond – CSHL
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Aberrant hypothalamic neuronal activity blunts glucocorticoid diurnal rhythms in murine breast cancer” by Jeremy Borniger et al. Neuron
Abstract
Aberrant hypothalamic neuronal activity blunts glucocorticoid diurnal rhythms in murine breast cancer
Patients with breast cancer frequently show disrupted diurnal rhythms of circulating glucocorticoids, such as cortisol. These disruptions correlate with lower quality of life and higher mortality, yet the underlying cause has been unclear.
In this study, mice bearing breast tumors developed blunted glucocorticoid rhythms and a loss of day-night variation in the activity of paraventricular hypothalamic neurons that express corticotropin-releasing hormone (PVNCRH). The altered PVNCRH activity resulted from disinhibition by upstream GABAergic neurons.
Using chemogenetic stimulation of PVNCRH neurons at different times of day, the researchers demonstrated that stimulating these neurons just before the light-to-dark transition restores normal glucocorticoid rhythms, reduces tumor progression, and increases intra-tumor effector CD8+ T cells. These findings indicate that breast tumors can remotely regulate hypothalamic neurons that control HPA axis output, and suggest that targeting neural circuits to restore physiological rhythms could support anti-tumor immunity and slow cancer growth.